PRA 헬스사이언스, 새롭게 건립하는 Global Center of Excellence for Decentralized Clinical Trial Strategy 총괄할 FDA 고위 인사 영입
23 nov. 2020 14h28 HE
|
PRA Health Sciences, Inc.
미국 노스캐롤라이나주 롤리, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA 헬스사이언스(PRA Health Sciences, Inc. (NASDAQ: PRAH))는 아이잭 로드리게스-차베스(Isaac Rodriguez-Chavez) 박사(공중보건학 석사, 이학 석사)를 과학, 임상 담당 부사장으로 선임한다고 발표했다....
PRA Health Sciences ernennt hochrangigen FDA-Beamten zum Leiter des neuen Global Center of Excellence for Decentralized Clinical Trial Strategy
23 nov. 2020 14h28 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) gab heute die Ernennung von Isaac Rodriguez-Chavez, PhD, MHS, MS, zum Senior Vice President, Scientific and...
PRA Health Sciences 任命高級 FDA 官員領導新全球分散式臨床試驗策略卓越中心
23 nov. 2020 14h28 HE
|
PRA Health Sciences, Inc.
北卡羅萊納州拉里格, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) 今天宣佈任命 Isaac Rodriguez-Chavez 博士、環境健康科學碩士兼理學碩士為科學和臨床事務高級副總裁。他將領導公司的全球分散式臨床試驗策略卓越中心。Rodriguez-Chavez 博士的職責包括實現...
PRA Health Sciences appoints senior FDA official to lead new Global Center of Excellence for Decentralized Clinical Trial Strategy
19 nov. 2020 16h02 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C. , Nov. 19, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today the appointment of Isaac Rodriguez-Chavez, PhD, MHS, MS, as Senior Vice President,...
PRA Health Sciences, Inc. Reports Third Quarter 2020 Results and Updates Full Year 2020 Guidance
04 nov. 2020 16h01 HE
|
PRA Health Sciences, Inc.
Net new business of $737.9 million; representing growth of 10.2%; Net book-to-bill of 1.28 excluding reimbursement revenueNet new business of $986.0 million; Net book-to-bill of 1.35 including...
PRA Health Sciences to Report Third Quarter 2020 Earnings
07 oct. 2020 17h09 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Oct. 07, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its third quarter 2020 results after the market closes on Wednesday, November 4, 2020. The...
PRA Health Sciences seleccionada por BARDA para formar parte de su Red de Estudios Clínicos exclusiva
07 oct. 2020 11h10 HE
|
PRA Health Sciences, Inc.
RALEIGH, Carolina del Norte, Oct. 07, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) anunció hoy que fue seleccionada por la Autoridad de Investigación y Desarrollo Avanzado...
PRAヘルスサイエンス、BARDAにより専門臨床研究ネットワークのメンバーに選出
07 oct. 2020 11h10 HE
|
PRA Health Sciences, Inc.
PRAは新たな契約の下、公衆衛生の医学的対策開発で生物医学先端研究開発局 (BARDA) を支援 ノースカロライナ州ローリー, Oct. 08, 2020 (GLOBE NEWSWIRE) -- PRAヘルスサイエンス (PRA Health Sciences, Inc.、NASDAQ: PRAH) は本日、生物医学先端研究開発局 (Biomedical Advanced Research...
PRA Health Sciences sélectionnée par la BARDA pour intégrer son réseau d'études cliniques exclusif
07 oct. 2020 11h10 HE
|
PRA Health Sciences, Inc.
RALEIGH, Caroline du Nord, 07 oct. 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ : PRAH) a annoncé aujourd'hui avoir été sélectionnée par la Biomedical Advanced Research and Development...
PRA Health Sciences被BARDA选为其独家临床研究网络的成员
07 oct. 2020 11h10 HE
|
PRA Health Sciences, Inc.
北卡罗来纳州罗利市, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Health Sciences, Inc.（NASDAQ：PRAH）今天宣布已被生物医学高级研究与发展管理局（BARDA）选为最新临床研究网络（CSN）的成员。按照临床试验规划和实施（CTPE）合同的规定，...